Skip to content

Zymeworks ZYME Interest coverage

Interest coverage at other companies

Amgen logo
AmgenAMGN
3.9×+1.5×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-49.3×-20.0×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-13×-15.9×
TG Therapeutics logo
TG TherapeuticsTGTX
5.4×+3.3×
Charles River Laboratories logo
Charles River LaboratoriesCRL
3.3×0.0×
TEC
Bio-TechneTECH
16.7×-0.8×

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Calculated from Zymeworks’s reported figures.

Based on trailing twelve months.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's interest coverage?
Zymeworks (ZYME) reported interest coverage of -9× in Q1 2026.
How has Zymeworks's interest coverage changed year-over-year?
Zymeworks's interest coverage decreased by 26.0% year-over-year, from -7.2× to -9×.
What is the long-term trend for Zymeworks's interest coverage?
Over 4 years (2020 to 2025), Zymeworks's interest coverage has grown at a -32.3% compound annual growth rate (CAGR), from -32.9× to -6.9×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.